SANUWAVE Health Q2 revenue falls, withdraws FY guidance amid Medicare reimbursement uncertainty

SANUWAVE Health

06/08/2026 22:13

Overview
US wound care device maker's Q2 revenue fell 3% yr/yr as system sales declined
Gross margin dropped to 76.2% from 78.1% a year earlier
Company withdrew 2026 guidance amid Medicare reimbursement uncertainty

Outlook
SANUWAVE withdraws fiscal 2026 guidance due to Medicare reimbursement uncertainty
Company will not provide guidance until after CMS issues final reimbursement rule, expected Q4 2026

Result Drivers
SYSTEM SALES DECLINE - Co said ongoing stress in customer base from CMS reimbursement changes and growth in used system market hurt new system sales
APPLICATOR SALES GROWTH - Ultramist applicator revenue rose 13% yr/yr, making up about 75% of Q2 revenue

Company press release: ID:nGNX1bd5Pp

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
 
$9.7 mln
 
Q2 Net Loss
 
$682,000
 
Q2 Gross Margin
 
76.2%
 
Q2 Operating Income
 
-$280,000
 

Analyst Coverage
The stock recently traded at 5 times the next 12-month earnings vs. a P/E of 29 three months ago

Reuters Recommended Reads
Aug 6 - CVRx Q2 revenue beats estimates, outlook cut on sales force, payer challenges
Aug 4 - Personalis Q2 revenue rises 30%, beats estimates on expanded Medicare coverage
Aug 6 - Outset Medical Q2 adjusted loss per share narrows less than expected

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)